Workflow
易普力(002096) - 2022 Q3 - 季度财报
EXPLEXPL(SZ:002096)2022-10-27 16:00

Financial Performance - The company's revenue for Q3 2022 was ¥547,858,073.44, representing a 12.98% increase compared to ¥483,954,665.51 in the same period last year[7]. - Net profit attributable to shareholders was ¥15,330,324.84, a decrease of 39.94% from ¥13,283,476.93 in the previous year[7]. - The net profit after deducting non-recurring gains and losses was ¥13,022,834.49, down 31.83% from ¥7,008,488.26 in the same period last year[7]. - Total operating revenue for the period reached ¥1,619,406,650.44, an increase of 19.6% compared to ¥1,342,007,853.33 in the previous period[42]. - Net profit for the period was ¥41,579,799.31, down 35.9% from ¥64,773,817.87 in the same period last year[46]. - The total comprehensive income for the period was ¥83,338,732.79, compared to ¥83,307,931.03 in the previous period, showing a marginal increase[48]. Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥150,228,335.96, an increase of 818.85% compared to ¥13,217,870.67 in the previous year[7]. - Operating cash inflow for the current period reached ¥1,814,870,820.60, an increase of 5.05% compared to ¥1,727,446,429.75 in the previous period[49]. - Cash inflow from investment activities totaled ¥55,192,171.67, compared to ¥11,621,504.69 in the previous period, marking a substantial increase[52]. - Cash received from tax refunds was ¥28,306,996.66, a significant increase from ¥600,000.00 in the previous period[49]. - The ending balance of cash and cash equivalents increased to ¥515,071,364.15 from ¥415,765,886.69 in the previous period[52]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,894,331,701.95, a decrease of 5.61% from the previous year's end[7]. - The company's total liabilities decreased to ¥1,705,182,606.45 from ¥2,005,155,913.73, reflecting a reduction of approximately 14.9%[41]. - The company's total assets amounted to RMB 3,675,737,533.55, a decrease from RMB 3,894,331,701.95 at the beginning of the year[32]. - The company reported a total current liabilities of RMB 630,000,000.00 in short-term borrowings as of September 30, 2022, down from RMB 658,762,500.00 at the beginning of the year[35]. Equity and Shareholder Information - The equity attributable to shareholders was ¥1,847,257,698.39, reflecting a 3.53% decrease compared to the previous year[7]. - The total equity attributable to shareholders of the parent company increased to ¥1,912,432,055.76, up from ¥1,847,257,698.39, representing a growth of 3.5%[41]. - Basic earnings per share were ¥0.0403, a decrease of 41.34% from ¥0.0358 in the same period last year[7]. - Basic earnings per share for the period were ¥0.0977, down from ¥0.1697 in the previous period, reflecting a decline of 42.4%[48]. Operational Metrics - Operating costs rose to $1.19 billion, an increase of 32.33% driven by higher raw material prices for civil explosives[16]. - Research and development expenses for the period were ¥55,931,214.42, slightly up from ¥53,453,825.87, indicating a focus on innovation[42]. - The company made adjustments to its financial statements due to the acquisition of three wholly-owned subsidiaries in October 2021, impacting comparative data[10]. Receivables and Inventory - Accounts receivable increased to $523.57 million, up 44.32% due to extended collection periods impacted by the pandemic[16]. - Other receivables surged to $227.21 million, a 181.68% increase primarily from the disposal of assets in the 169 shantytown redevelopment project[16]. - Inventory decreased to $338.76 million, down 58.52% as a result of asset disposals[16]. - The company's inventory decreased to RMB 338,758,336.93 from RMB 816,608,473.27, representing a decline of approximately 58.6%[35]. Government Support and Regulatory Matters - The company received government subsidies amounting to ¥2,874,688.92 during the reporting period, contributing to its financial performance[11]. - The company has received approval from the China Securities Regulatory Commission (CSRC) to resume the review of its asset acquisition and fundraising plan[31]. - The company has applied to the CSRC for a suspension of the review of its restructuring matters due to the need for additional auditing of financial data[30].